294
Views
24
CrossRef citations to date
0
Altmetric
Theme: Stroke - Review

Obstructive sleep apnea and stroke

&
Pages 525-535 | Published online: 10 Jan 2014

References

  • The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specification (1st Edition). Iber C, Ancoli-Israel S, Chesson A, Quan Sf (Eds). American Academy of Sleep Medicine, Westchester, IL, USA (2007).
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365(9464), 1046–1053 (2005).
  • Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328(17), 1230–1235 (1993).
  • Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med.165(9), 1217–1239 (2002).
  • Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J. Clin. Sleep Med.6(2), 131–137 (2010).
  • Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin. Proc.79(8), 1036–1046 (2004).
  • Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA283(14), 1829–1836 (2000).
  • Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med.342(19), 1378–1384 (2000).
  • Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens.19(12), 2271–2277 (2001).
  • Haentjens P, van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch. Intern. Med.167(8), 757–764 (2007).
  • Logan AG, Tkacova R, Perlikowski SM et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur. Respir. J.21(2), 241–247 (2003).
  • Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, Martinez TG, Bernacer-Alpera B, Roman-Sanchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur. Respir. J.29(5), 951–957 (2007).
  • Resnick HE, Redline S, Shahar E et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care26(3), 702–709 (2003).
  • Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and Type II diabetes: a population-based study. Am. J. Respir. Crit. Care Med.172(12), 1590–1595 (2005).
  • Aronsohn RS, Whitmore H, van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in Type 2 diabetes. Am. J. Respir. Crit. Care Med.181(5), 507–513 (2010).
  • Iiyori N, Alonso LC, Li J et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med.175(8), 851–857 (2007).
  • Polotsky VY, Li J, Punjabi NM et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol.552(Pt 1), 253–264 (2003).
  • Yokoe T, Alonso LC, Romano LC et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J. Physiol.586(3), 899–911 (2008).
  • Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for Type 2 diabetes. Am. J. Med.122(12), 1122–1127 (2009).
  • Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med.165(4), 447–452 (2005).
  • Dawson A, Abel SL, Loving RTT et al. CPAP therapy of obstructive sleep apnea in Type 2 diabetics improves glycemic control during sleep. J. Clin. Sleep Med.4(6), 538–542 (2008).
  • Harsch IAA, Schahin SP, Bruckner K et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and Type 2 diabetes. Respiration71(3), 252–259 (2004).
  • Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract.81(1), e8–e11 (2008).
  • West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and Type 2 diabetes. Thorax62(11), 969–974 (2007).
  • Gami AS, Pressman G, Caples SM et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation110(4), 364–367 (2004).
  • Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am. J. Cardiol.52(5), 490–494 (1983).
  • Fichter J, Bauer D, Arampatzis S, Fries R, Heisel A, Sybrecht GW. Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest122(2), 558–561 (2002).
  • Niroumand M, Kuperstein R, Sasson Z, Hanly PJ. Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am. J. Respir. Crit. Care Med.163(7), 1632–1636 (2001).
  • Hall MJ, Ando S, Floras JS, Bradley TD. Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J. Appl. Physiol.85(4), 1476–1484 (1998).
  • Alchanatis M, Paradellis G, Pini H, Tourkohoriti G, Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration67(4), 367–371 (2000).
  • Fung JW, Li TS, Choy DK et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest121(2), 422–429 (2002).
  • Gami AS, Hodge DO, Herges RM et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J. Am. Coll. Cardiol.49(5), 565–571 (2007).
  • Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation107(20), 2589–2594 (2003).
  • Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am. J. Cardiol.108(1), 47–51 (2011).
  • Beelke M, Angeli S, Del Sette M et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med.4(3), 219–223 (2003).
  • Shanoudy H, Soliman A, Raggi P, Liu JW, Russell DC, Jarmukli NF. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest113(1), 91–96 (1998).
  • Beelke M, Angeli S, Del Sette M et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep25(8), 856–862 (2002).
  • Marshall J. Diurnal variation in occurrence of strokes. Stroke8(2), 230–231 (1977).
  • Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke29(5), 992–996 (1998).
  • Franklin KA. Cerebral haemodynamics in obstructive sleep apnoea and Cheyne–Stokes respiration. Sleep Med. Rev.6(6), 429–441 (2002).
  • Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am. J. Respir. Crit. Care Med.150(6 Pt 1), 1587–1591 (1994).
  • Santiago TV, Guerra E, Neubauer JA, Edelman NH. Correlation between ventilation and brain blood flow during sleep. J. Clin. Invest.73(2), 497–506 (1984).
  • Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Factors affecting the difference between morning and evening home blood pressure: the Finn–Home study. Blood Press20(1), 27–36 (2010).
  • Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation107(10), 1401–1406 (2003).
  • Tofler GH, Brezinski D, Schafer AI et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N. Engl. J. Med.316(24), 1514–1518 (1987).
  • Andreotti F, Davies GJ, Hackett DR et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am. J. Cardiol.62(9), 635–637 (1988).
  • Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am. J. Respir. Crit. Care Med.162(6), 2039–2042 (2000).
  • Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration69(3), 229–234 (2002).
  • Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest108(3), 625–630 (1995).
  • Shimizu M, Kamio K, Haida M et al. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure. Tokai J. Exp. Clin. Med.27(4), 107–112 (2002).
  • von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Loredo JS, Dimsdale JE. Day/night rhythm of hemostatic factors in obstructive sleep apnea. Sleep33(3), 371–377 (2010).
  • Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest95(2), 279–283 (1989).
  • Fischer AQ, Chaudhary BA, Taormina MA, Akhtar B. Intracranial hemodynamics in sleep apnea. Chest102(5), 1402–1406 (1992).
  • Joo EY, Tae WS, Han SJ, Cho JW, Hong SB. Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome. Sleep30(11), 1515–1520 (2007).
  • Netzer N, Werner P, Jochums I, Lehmann M, Strohl KP. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke29(1), 87–93 (1998).
  • Morgan BJ, Reichmuth KJ, Peppard PE et al. Effects of sleep-disordered breathing on cerebrovascular regulation: a population-based study. Am. J. Respir. Crit. Care Med.182(11), 1445–1452 (2010).
  • Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J. Appl. Physiol.105(6), 1852–1857 (2008).
  • Nasr N, Traon AP, Czosnyka M, Tiberge M, Schmidt E, Larrue V. Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. Eur. J. Neurol.16(3), 386–391 (2009).
  • Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am. J. Respir. Crit. Care Med.169(3), 348–353 (2004).
  • El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest121(5), 1541–1547 (2002).
  • Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med.165(7), 934–939 (2002).
  • Ohga E, Nagase T, Tomita T et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J. Appl. Physiol.87(1), 10–14 (1999).
  • Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation107(8), 1129–1134 (2003).
  • Chin K, Ohi M, Kita H et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med.153(6 Pt 1), 1972–1976 (1996).
  • Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis10(1), 1–7 (1990).
  • Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med.311(8), 501–505 (1984).
  • Hui DS, Ko FW, Fok JP et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest125(5), 1768–1775 (2004).
  • Rahangdale S, Yeh SY, Novack V et al. The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea. J. Clin. Sleep Med.7(2), 172–178 (2011).
  • Oga T, Chin K, Tabuchi A et al. Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability. J. Atheroscler. Thromb.16(6), 862–869 (2009).
  • Spriggs DA, French JM, Murdy JM, Curless RH, Bates D, James OF. Snoring increases the risk of stroke and adversely affects prognosis. Q J Med.83(303), 555–562 (1992).
  • Smirne S, Palazzi S, Zucconi M, Chierchia S, Ferini-Strambi L. Habitual snoring as a risk factor for acute vascular disease. Eur. Respir. J.6(9), 1357–1361 (1993).
  • Neau JP, Meurice JC, Paquereau J, Chavagnat JJ, Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol. Scand.92(1), 63–68 (1995).
  • Lee MC, Klassen AC, Heaney LM, Resch JA. Respiratory rate and pattern disturbances in acute brain stem infarction. Stroke7(4), 382–385 (1976).
  • Chaudhary BA, Elguindi AS, King DW. Obstructive sleep apnea after lateral medullary syndrome. South. Med. J.75(1), 65–67 (1982).
  • Askenasy JJ, Goldhammer I. Sleep apnea as a feature of bulbar stroke. Stroke19(5), 637–639 (1988).
  • North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch. Neurol.31(5), 338–344 (1974).
  • Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke37(4), 967–972 (2006).
  • Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke27(2), 252–259 (1996).
  • Parra O, Arboix A, Bechich S et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am. J. Respir. Crit. Care Med.161(2 Pt 1), 375–380 (2000).
  • Bravata DM, Concato J, Fried T et al. Continuous positive airway pressure: evaluation of a novel therapy for patients with acute ischemic stroke. Sleep34(9), 1271–1277 (2011).
  • Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep22(2), 217–223 (1999).
  • Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med.163(1), 19–25 (2001).
  • Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am. J. Respir. Crit. Care Med.172(11), 1447–1451 (2005).
  • Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation118(9), 955–960 (2008).
  • Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med.353(19), 2034–2041 (2005).
  • Munoz R, Duran-Cantolla J, Martinez-Vila E et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke37(9), 2317–2321 (2006).
  • Redline S, Yenokyan G, Gottlieb DJ et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care Med.182(2), 269–277 (2010).
  • Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep23(Suppl. 4), S102–S108 (2000).
  • Decary A, Rouleau I, Montplaisir J. Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep23(3), 369–381 (2000).
  • Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke27(3), 401–407 (1996).
  • Parra O, Arboix A, Montserrat JM, Quinto L, Bechich S, Garcia-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur. Respir. J.24(2), 267–272 (2004).
  • Turkington PM, Allgar V, Bamford J, Wanklyn P, Elliott MW. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax59(5), 367–371 (2004).
  • Kaneko Y, Hajek VE, Zivanovic V, Raboud J, Bradley TD. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep26(3), 293–297 (2003).
  • Sahlin C, Sandberg O, Gustafson Y et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch. Intern. Med.168(3), 297–301 (2008).
  • Wessendorf TE, Wang YM, Thilmann AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur. Respir. J.18(4), 623–629 (2001).
  • Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J. Neurol. Neurosurg. Psychiatry77(10), 1143–1149 (2006).
  • Hui DS, Choy DK, Wong LK et al. Prevalence of sleep-disordered breathing and continuous positive airway pressure compliance: results in Chinese patients with first-ever ischemic stroke. Chest122(3), 852–860 (2002).
  • Martinez-Garcia MA, Galiano-Blancart R, Roman-Sanchez P, Soler-Cataluna JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest128(4), 2123–2129 (2005).
  • Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur. J. Neurol.13(2), 198–200 (2006).
  • Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur. Respir. J.18(4), 630–634 (2001).
  • Martinez-Garcia MA, Campos-Rodriguez F, Soler-Cataluna JJ, Catalan-Serra P, Roman-Sanchez P, Montserrat JM. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea. Effect of CPAP treatment. Eur. Respir. J. doi:10.1183/09031936.00011311 (2011) (Epub ahead of print).
  • Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am. J. Respir. Crit. Care Med.180(1), 36–41 (2009).
  • Bravata DM, Concato J, Fried T et al. Autotitrating continuous positive airway pressure for patients with acute transient ischemic attack: a randomized feasibility trial. Stroke41(7), 1464–1470 (2010).
  • Ryan CM, Bayley M, Green R, Murray BJ, Bradley TD. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke42(4), 1062–1067 (2011).
  • Parra O, Sanchez-Armengol A, Bonnin M et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur. Respir. J.37(5), 1128–1136 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.